Clinical Trials Directory

Trials / Completed

CompletedNCT05030402

Efficacy of Maitland Mobilization in Shoulder Pathology

Effec of Maitland in Shoulder Pathology

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
63 (actual)
Sponsor
University of Las Palmas de Gran Canaria · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The shoulder is a mobile structure which generates a lot of pathologies. One of them is rotator cuff tendinosis. On the other hand, it has been investigated that Maitland is effective for reducing pain and for mobility in the cervical and lumbar spine and in joints such as the knee and ankle, however, there are few studies that confirm that it is effective in shoulder pathologies.So here the investigatprs want to study the effectiveness of Maitland as an adjunctive treatment for shoulder pathologies, comparing it with conventional physiotherapy treatment, in relation to the reduction of pain and increased mobility. For that the investigators have a randomized clinical trial with two group.

Detailed description

Group 1 receives tens, SW, conventional physiotherapy and exercises as treatment. Group 2 receives tens, SW, Mailtland, and exercises. An assessment is carried out at the beginning of the treatment, at the end and 2-4 weeks after finishing the treatment. The EVA ASES, DASH and SF-36 scales are included and the biomechanics study is used for the range of mobility.

Conditions

Interventions

TypeNameDescription
PROCEDUREMaitlandAn assessment is carried out at the beginning of the treatment, at the end and 2-4 weeks after finishing the treatment. The EVA ASES, DASH and SF-36 scales are included and the biomechanics study is used for the range of mobility.
PROCEDURETens, exercise, SWAn assessment is carried out at the beginning of the treatment, at the end and 2-4 weeks after finishing the treatment. The EVA ASES, DASH and SF-36 scales are included and the biomechanics study is used for the range of mobility.
PROCEDUREConventional physiotherapyAn assessment is carried out at the beginning of the treatment, at the end and 2-4 weeks after finishing the treatment. The EVA ASES, DASH and SF-36 scales are included and the biomechanics study is used for the range of mobility.

Timeline

Start date
2020-09-03
Primary completion
2021-10-31
Completion
2022-10-31
First posted
2021-09-01
Last updated
2022-11-30

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT05030402. Inclusion in this directory is not an endorsement.